
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 45 | 67.27 | 67.75 | 4 |
| 15 | 67.25 | 68.26 | 6 |
| 44 | 67.23 | 68.27 | 128 |
| 5 | 67.12 | 69.07 | 121 |
| 3 | 67.07 | 69.20 | 148 |
| 18821 | Total | Total | 11183 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 45 | 67.27 | 67.75 | 4 |
| 15 | 67.25 | 68.26 | 6 |
| 44 | 67.23 | 68.27 | 128 |
| 5 | 67.12 | 69.07 | 121 |
| 3 | 67.07 | 69.20 | 148 |
| 18821 | Total | Total | 11183 |
| Open | 69.90 |
| Previous Close | 68.49 |
| Volume | 14,909.00 |
| Value (Lacs) | 9.98 |
| VWAP | 68.88 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 363 |
| High | 70.85 |
| Low | 66.61 |
| UC Limit | 82.18 |
| LC Limit | 54.80 |
| 52 Week High | 130.20 |
| 52 Week Low | 63.86 |
| Face Value | 10.00 |
| All Time High | 214.95 |
| All Time Low | 63.86 |
| 20D Avg Volume | 241,054 |
| 20D Avg Delivery(%) | 11.01 |
| Book Value Per Share | 58.14 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 0.93 (+150.57% YoY) |
| TTM PE See historical trend | 71.96 (Average PE) |
| P/B See historical trend | 1.16 (Low P/B) |
| Sector PE | 39.56 |
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
2 out of 3 years Valiant Laboratories has given negative returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 1.63% | 1.63% | -4.31% (2023) | -4.28% | -2.31% |
Valiant Lab Standalone September 2025 Net Sales at Rs 45.99 crore, up 114.11% Y-o-Y Nov 12 2025 03:09 PM
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y Aug 22 2025 01:15 PM
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y May 22 2025 11:17 AM
Valiant Lab Standalone March 2025 Net Sales at Rs 57.77 crore, up 88.9% Y-o-Y May 21 2025 10:38 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 235200 | Price 120.29 | % Traded 0.43 |
| Qty 275000 | Price 102.75 | % Traded 0.51 |
| Qty 275000 | Price 102.75 | % Traded 0.51 |
| Qty 550000 | Price 105.78 | % Traded 1.02 |
| Qty 550000 | Price 105.77 | % Traded 1.02 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Valiant Lab | 68.00 | -0.72 | 369.32 | 73.12 | 1.17 | -0.93 | -44.61 | -2 | 133 | 0.52 |
| Sun Pharma | 1,775.20 | -1.17 | 425,929.94 | 40.76 | 5.90 | 15.13 | -1.74 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,272.00 | -0.89 | 166,501.89 | 67.00 | 11.12 | 14.63 | 5.24 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,761.70 | 0.05 | 127,313.02 | 59.49 | 16.97 | 25.17 | 12.77 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,489.00 | -0.57 | 120,277.13 | 22.11 | 3.86 | 16.90 | 1.36 | 5,291 | 27,547 | 0.00 |